nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP2D6—Hydroxyurea—head and neck cancer	0.0937	0.238	CbGbCtD
Quetiapine—CYP3A7—Docetaxel—head and neck cancer	0.0594	0.151	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0594	0.151	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—head and neck cancer	0.0446	0.113	CbGbCtD
Quetiapine—ABCB1—Vinblastine—head and neck cancer	0.0352	0.0896	CbGbCtD
Quetiapine—CYP2D6—Vinblastine—head and neck cancer	0.0332	0.0844	CbGbCtD
Quetiapine—ABCB1—Docetaxel—head and neck cancer	0.029	0.0738	CbGbCtD
Quetiapine—DRD5—eyelid—head and neck cancer	0.0224	0.125	CbGeAlD
Quetiapine—CYP3A4—Vinblastine—head and neck cancer	0.0211	0.0537	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—head and neck cancer	0.0174	0.0442	CbGbCtD
Quetiapine—HTR7—superior cervical ganglion—head and neck cancer	0.0138	0.077	CbGeAlD
Quetiapine—HTR1B—trigeminal nerve—head and neck cancer	0.0101	0.0564	CbGeAlD
Quetiapine—HTR1D—trigeminal nerve—head and neck cancer	0.0098	0.0546	CbGeAlD
Quetiapine—HTR3A—cranial nerve—head and neck cancer	0.00859	0.0479	CbGeAlD
Quetiapine—HRH1—nose—head and neck cancer	0.00743	0.0414	CbGeAlD
Quetiapine—HTR1B—cranial nerve—head and neck cancer	0.00721	0.0402	CbGeAlD
Quetiapine—HTR1D—cranial nerve—head and neck cancer	0.00698	0.0389	CbGeAlD
Quetiapine—HTR7—cranial nerve—head and neck cancer	0.00556	0.031	CbGeAlD
Quetiapine—HTR2A—trigeminal nerve—head and neck cancer	0.00487	0.0271	CbGeAlD
Quetiapine—H1F0—hair follicle—head and neck cancer	0.00387	0.0215	CbGeAlD
Quetiapine—HTR2A—cranial nerve—head and neck cancer	0.00347	0.0193	CbGeAlD
Quetiapine—CHRM3—exocrine gland—head and neck cancer	0.00263	0.0147	CbGeAlD
Quetiapine—H1F0—neck—head and neck cancer	0.00259	0.0145	CbGeAlD
Quetiapine—H1F0—parotid gland—head and neck cancer	0.00211	0.0118	CbGeAlD
Quetiapine—CHRM5—epithelium—head and neck cancer	0.00205	0.0114	CbGeAlD
Quetiapine—H1F0—saliva-secreting gland—head and neck cancer	0.00202	0.0113	CbGeAlD
Quetiapine—HTR7—mouth—head and neck cancer	0.00187	0.0104	CbGeAlD
Quetiapine—H1F0—connective tissue—head and neck cancer	0.00186	0.0104	CbGeAlD
Quetiapine—HTR1E—head—head and neck cancer	0.00185	0.0103	CbGeAlD
Quetiapine—ADRA1D—epithelium—head and neck cancer	0.00183	0.0102	CbGeAlD
Quetiapine—DRD5—lymphoid tissue—head and neck cancer	0.00176	0.00979	CbGeAlD
Quetiapine—CHRM4—head—head and neck cancer	0.00163	0.00906	CbGeAlD
Quetiapine—HTR7—neck—head and neck cancer	0.0016	0.00892	CbGeAlD
Quetiapine—H1F0—trachea—head and neck cancer	0.00156	0.0087	CbGeAlD
Quetiapine—CHRM1—parotid gland—head and neck cancer	0.00153	0.00853	CbGeAlD
Quetiapine—DRD3—head—head and neck cancer	0.00151	0.00842	CbGeAlD
Quetiapine—CHRM1—saliva-secreting gland—head and neck cancer	0.00147	0.00817	CbGeAlD
Quetiapine—HTR6—head—head and neck cancer	0.00145	0.0081	CbGeAlD
Quetiapine—HTR1D—connective tissue—head and neck cancer	0.00144	0.00803	CbGeAlD
Quetiapine—DRD5—head—head and neck cancer	0.00142	0.00789	CbGeAlD
Quetiapine—Dysuria—Hydroxyurea—head and neck cancer	0.00137	0.00472	CcSEcCtD
Quetiapine—Neutropenia—Hydroxyurea—head and neck cancer	0.00137	0.00472	CcSEcCtD
Quetiapine—Disorientation—Fluorouracil—head and neck cancer	0.00136	0.00469	CcSEcCtD
Quetiapine—H1F0—lymphoid tissue—head and neck cancer	0.00136	0.00758	CbGeAlD
Quetiapine—Agranulocytosis—Vinblastine—head and neck cancer	0.00133	0.0046	CcSEcCtD
Quetiapine—Weight increased—Hydroxyurea—head and neck cancer	0.00133	0.00459	CcSEcCtD
Quetiapine—CHRM3—saliva-secreting gland—head and neck cancer	0.00131	0.00731	CbGeAlD
Quetiapine—Drug interaction—Docetaxel—head and neck cancer	0.00131	0.0045	CcSEcCtD
Quetiapine—Infestation NOS—Hydroxyurea—head and neck cancer	0.0013	0.0045	CcSEcCtD
Quetiapine—Infestation—Hydroxyurea—head and neck cancer	0.0013	0.0045	CcSEcCtD
Quetiapine—Amnesia—Fluorouracil—head and neck cancer	0.0013	0.00447	CcSEcCtD
Quetiapine—Haemoglobin—Vinblastine—head and neck cancer	0.00129	0.00445	CcSEcCtD
Quetiapine—Haemorrhage—Vinblastine—head and neck cancer	0.00128	0.00443	CcSEcCtD
Quetiapine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00128	0.0044	CcSEcCtD
Quetiapine—Pharyngitis—Vinblastine—head and neck cancer	0.00127	0.00439	CcSEcCtD
Quetiapine—Stomatitis—Hydroxyurea—head and neck cancer	0.00127	0.00438	CcSEcCtD
Quetiapine—CHRM5—head—head and neck cancer	0.00127	0.00708	CbGeAlD
Quetiapine—Bone pain—Docetaxel—head and neck cancer	0.00126	0.00436	CcSEcCtD
Quetiapine—Lethargy—Fluorouracil—head and neck cancer	0.00124	0.00429	CcSEcCtD
Quetiapine—H1F0—thyroid gland—head and neck cancer	0.00123	0.00688	CbGeAlD
Quetiapine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00123	0.00425	CcSEcCtD
Quetiapine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00122	0.0042	CcSEcCtD
Quetiapine—Pulmonary embolism—Docetaxel—head and neck cancer	0.00121	0.00418	CcSEcCtD
Quetiapine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00121	0.00418	CcSEcCtD
Quetiapine—ADRA2C—parotid gland—head and neck cancer	0.0012	0.00668	CbGeAlD
Quetiapine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00118	0.00406	CcSEcCtD
Quetiapine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00117	0.00404	CcSEcCtD
Quetiapine—Hallucination—Hydroxyurea—head and neck cancer	0.00117	0.00402	CcSEcCtD
Quetiapine—Irritability—Fluorouracil—head and neck cancer	0.00116	0.00401	CcSEcCtD
Quetiapine—ADRA1B—head—head and neck cancer	0.00116	0.00647	CbGeAlD
Quetiapine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00116	0.00399	CcSEcCtD
Quetiapine—Candida infection—Docetaxel—head and neck cancer	0.00116	0.00399	CcSEcCtD
Quetiapine—HTR7—connective tissue—head and neck cancer	0.00115	0.00639	CbGeAlD
Quetiapine—Ataxia—Fluorouracil—head and neck cancer	0.00115	0.00395	CcSEcCtD
Quetiapine—ADRA1D—head—head and neck cancer	0.00114	0.00633	CbGeAlD
Quetiapine—CHRM1—trachea—head and neck cancer	0.00113	0.0063	CbGeAlD
Quetiapine—Dry skin—Fluorouracil—head and neck cancer	0.00112	0.00385	CcSEcCtD
Quetiapine—H1F0—head—head and neck cancer	0.0011	0.0061	CbGeAlD
Quetiapine—Neoplasm—Docetaxel—head and neck cancer	0.0011	0.00378	CcSEcCtD
Quetiapine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00109	0.00376	CcSEcCtD
Quetiapine—HTR7—epithelium—head and neck cancer	0.00109	0.00607	CbGeAlD
Quetiapine—DRD1—head—head and neck cancer	0.00108	0.00603	CbGeAlD
Quetiapine—Muscular weakness—Fluorouracil—head and neck cancer	0.00107	0.0037	CcSEcCtD
Quetiapine—Angiopathy—Hydroxyurea—head and neck cancer	0.00106	0.00366	CcSEcCtD
Quetiapine—Dysphagia—Fluorouracil—head and neck cancer	0.00105	0.00363	CcSEcCtD
Quetiapine—Chills—Hydroxyurea—head and neck cancer	0.00105	0.00362	CcSEcCtD
Quetiapine—ADRA1A—epithelium—head and neck cancer	0.00105	0.00585	CbGeAlD
Quetiapine—HTR3A—head—head and neck cancer	0.00104	0.00582	CbGeAlD
Quetiapine—Eosinophilia—Fluorouracil—head and neck cancer	0.00104	0.00359	CcSEcCtD
Quetiapine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00104	0.00358	CcSEcCtD
Quetiapine—Anaemia—Vinblastine—head and neck cancer	0.00103	0.00356	CcSEcCtD
Quetiapine—Angina pectoris—Fluorouracil—head and neck cancer	0.00103	0.00354	CcSEcCtD
Quetiapine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00102	0.0035	CcSEcCtD
Quetiapine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00101	0.00349	CcSEcCtD
Quetiapine—Malaise—Vinblastine—head and neck cancer	0.00101	0.00347	CcSEcCtD
Quetiapine—Vertigo—Vinblastine—head and neck cancer	0.001	0.00346	CcSEcCtD
Quetiapine—Leukopenia—Vinblastine—head and neck cancer	0.001	0.00345	CcSEcCtD
Quetiapine—HTR2A—neck—head and neck cancer	0.000998	0.00556	CbGeAlD
Quetiapine—Deafness—Docetaxel—head and neck cancer	0.000983	0.00339	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000979	0.00337	CcSEcCtD
Quetiapine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00097	0.00334	CcSEcCtD
Quetiapine—Convulsion—Vinblastine—head and neck cancer	0.000969	0.00334	CcSEcCtD
Quetiapine—Hypertension—Vinblastine—head and neck cancer	0.000965	0.00333	CcSEcCtD
Quetiapine—HTR7—trachea—head and neck cancer	0.000963	0.00537	CbGeAlD
Quetiapine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000961	0.00331	CcSEcCtD
Quetiapine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000946	0.00326	CcSEcCtD
Quetiapine—Pneumonia—Fluorouracil—head and neck cancer	0.000944	0.00326	CcSEcCtD
Quetiapine—Anaemia—Hydroxyurea—head and neck cancer	0.000942	0.00325	CcSEcCtD
Quetiapine—Discomfort—Vinblastine—head and neck cancer	0.00094	0.00324	CcSEcCtD
Quetiapine—Hot flush—Docetaxel—head and neck cancer	0.00094	0.00324	CcSEcCtD
Quetiapine—Infestation NOS—Fluorouracil—head and neck cancer	0.000939	0.00324	CcSEcCtD
Quetiapine—Infestation—Fluorouracil—head and neck cancer	0.000939	0.00324	CcSEcCtD
Quetiapine—Menopausal symptoms—Docetaxel—head and neck cancer	0.000932	0.00321	CcSEcCtD
Quetiapine—Atrial fibrillation—Docetaxel—head and neck cancer	0.000928	0.0032	CcSEcCtD
Quetiapine—Malaise—Hydroxyurea—head and neck cancer	0.000919	0.00317	CcSEcCtD
Quetiapine—Stomatitis—Fluorouracil—head and neck cancer	0.000915	0.00315	CcSEcCtD
Quetiapine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000913	0.00315	CcSEcCtD
Quetiapine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000913	0.00315	CcSEcCtD
Quetiapine—Leukopenia—Hydroxyurea—head and neck cancer	0.000913	0.00315	CcSEcCtD
Quetiapine—Lethargy—Docetaxel—head and neck cancer	0.000897	0.00309	CcSEcCtD
Quetiapine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000893	0.00308	CcSEcCtD
Quetiapine—Epistaxis—Fluorouracil—head and neck cancer	0.000886	0.00305	CcSEcCtD
Quetiapine—ADRA2C—trachea—head and neck cancer	0.000885	0.00493	CbGeAlD
Quetiapine—Convulsion—Hydroxyurea—head and neck cancer	0.000883	0.00304	CcSEcCtD
Quetiapine—Hyponatraemia—Docetaxel—head and neck cancer	0.000883	0.00304	CcSEcCtD
Quetiapine—Sinusitis—Fluorouracil—head and neck cancer	0.000881	0.00304	CcSEcCtD
Quetiapine—Pain in extremity—Docetaxel—head and neck cancer	0.000879	0.00303	CcSEcCtD
Quetiapine—HTR1B—head—head and neck cancer	0.000877	0.00488	CbGeAlD
Quetiapine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000876	0.00302	CcSEcCtD
Quetiapine—CHRM2—head—head and neck cancer	0.000872	0.00486	CbGeAlD
Quetiapine—Anorexia—Vinblastine—head and neck cancer	0.00087	0.003	CcSEcCtD
Quetiapine—Migraine—Docetaxel—head and neck cancer	0.000866	0.00298	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000862	0.00297	CcSEcCtD
Quetiapine—Discomfort—Hydroxyurea—head and neck cancer	0.000857	0.00296	CcSEcCtD
Quetiapine—HRH1—connective tissue—head and neck cancer	0.000857	0.00477	CbGeAlD
Quetiapine—HTR1D—head—head and neck cancer	0.000849	0.00473	CbGeAlD
Quetiapine—Haemoglobin—Fluorouracil—head and neck cancer	0.000847	0.00292	CcSEcCtD
Quetiapine—Rhinitis—Fluorouracil—head and neck cancer	0.000845	0.00291	CcSEcCtD
Quetiapine—Haemorrhage—Fluorouracil—head and neck cancer	0.000843	0.00291	CcSEcCtD
Quetiapine—ADRA2A—connective tissue—head and neck cancer	0.000842	0.00469	CbGeAlD
Quetiapine—HTR2C—head—head and neck cancer	0.00084	0.00468	CbGeAlD
Quetiapine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000839	0.00289	CcSEcCtD
Quetiapine—Pharyngitis—Fluorouracil—head and neck cancer	0.000837	0.00288	CcSEcCtD
Quetiapine—Ataxia—Docetaxel—head and neck cancer	0.000827	0.00285	CcSEcCtD
Quetiapine—Infection—Hydroxyurea—head and neck cancer	0.000827	0.00285	CcSEcCtD
Quetiapine—Paraesthesia—Vinblastine—head and neck cancer	0.000819	0.00282	CcSEcCtD
Quetiapine—Dehydration—Docetaxel—head and neck cancer	0.000818	0.00282	CcSEcCtD
Quetiapine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000816	0.00281	CcSEcCtD
Quetiapine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000815	0.00281	CcSEcCtD
Quetiapine—HRH1—epithelium—head and neck cancer	0.000813	0.00453	CbGeAlD
Quetiapine—ADRA1A—lymphoid tissue—head and neck cancer	0.000809	0.00451	CbGeAlD
Quetiapine—Skin disorder—Hydroxyurea—head and neck cancer	0.000808	0.00279	CcSEcCtD
Quetiapine—Dry skin—Docetaxel—head and neck cancer	0.000806	0.00278	CcSEcCtD
Quetiapine—Abdominal pain upper—Docetaxel—head and neck cancer	0.000803	0.00277	CcSEcCtD
Quetiapine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000803	0.00277	CcSEcCtD
Quetiapine—CHRM3—thyroid gland—head and neck cancer	0.000801	0.00446	CbGeAlD
Quetiapine—Breast disorder—Docetaxel—head and neck cancer	0.000795	0.00274	CcSEcCtD
Quetiapine—CHRM1—head—head and neck cancer	0.000794	0.00442	CbGeAlD
Quetiapine—Anorexia—Hydroxyurea—head and neck cancer	0.000793	0.00273	CcSEcCtD
Quetiapine—Decreased appetite—Vinblastine—head and neck cancer	0.000793	0.00273	CcSEcCtD
Quetiapine—Cramp muscle—Docetaxel—head and neck cancer	0.000792	0.00273	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000792	0.00273	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000792	0.00273	CcSEcCtD
Quetiapine—Nasopharyngitis—Docetaxel—head and neck cancer	0.000786	0.00271	CcSEcCtD
Quetiapine—Pain—Vinblastine—head and neck cancer	0.00078	0.00269	CcSEcCtD
Quetiapine—Constipation—Vinblastine—head and neck cancer	0.00078	0.00269	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000776	0.00267	CcSEcCtD
Quetiapine—H1F0—lymph node—head and neck cancer	0.000767	0.00427	CbGeAlD
Quetiapine—Dysphagia—Docetaxel—head and neck cancer	0.00076	0.00262	CcSEcCtD
Quetiapine—Feeling abnormal—Vinblastine—head and neck cancer	0.000752	0.00259	CcSEcCtD
Quetiapine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000746	0.00257	CcSEcCtD
Quetiapine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000742	0.00256	CcSEcCtD
Quetiapine—Angina pectoris—Docetaxel—head and neck cancer	0.00074	0.00255	CcSEcCtD
Quetiapine—Somnolence—Hydroxyurea—head and neck cancer	0.00074	0.00255	CcSEcCtD
Quetiapine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000732	0.00252	CcSEcCtD
Quetiapine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000723	0.00249	CcSEcCtD
Quetiapine—Abdominal pain—Vinblastine—head and neck cancer	0.000721	0.00249	CcSEcCtD
Quetiapine—HRH1—trachea—head and neck cancer	0.000719	0.00401	CbGeAlD
Quetiapine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000718	0.00248	CcSEcCtD
Quetiapine—Fatigue—Hydroxyurea—head and neck cancer	0.000717	0.00247	CcSEcCtD
Quetiapine—HTR2A—connective tissue—head and neck cancer	0.000716	0.00399	CbGeAlD
Quetiapine—Pain—Hydroxyurea—head and neck cancer	0.000711	0.00245	CcSEcCtD
Quetiapine—Constipation—Hydroxyurea—head and neck cancer	0.000711	0.00245	CcSEcCtD
Quetiapine—Neutropenia—Docetaxel—head and neck cancer	0.000711	0.00245	CcSEcCtD
Quetiapine—CHRM3—head—head and neck cancer	0.00071	0.00396	CbGeAlD
Quetiapine—HTR1A—head—head and neck cancer	0.000707	0.00394	CbGeAlD
Quetiapine—ADRA2A—trachea—head and neck cancer	0.000706	0.00394	CbGeAlD
Quetiapine—Weight increased—Docetaxel—head and neck cancer	0.000692	0.00238	CcSEcCtD
Quetiapine—Vision blurred—Fluorouracil—head and neck cancer	0.000692	0.00238	CcSEcCtD
Quetiapine—Weight decreased—Docetaxel—head and neck cancer	0.000688	0.00237	CcSEcCtD
Quetiapine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000686	0.00236	CcSEcCtD
Quetiapine—Pneumonia—Docetaxel—head and neck cancer	0.000682	0.00235	CcSEcCtD
Quetiapine—HTR2A—epithelium—head and neck cancer	0.000679	0.00379	CbGeAlD
Quetiapine—Anaemia—Fluorouracil—head and neck cancer	0.000678	0.00234	CcSEcCtD
Quetiapine—Infestation—Docetaxel—head and neck cancer	0.000678	0.00234	CcSEcCtD
Quetiapine—Infestation NOS—Docetaxel—head and neck cancer	0.000678	0.00234	CcSEcCtD
Quetiapine—HTR7—head—head and neck cancer	0.000676	0.00377	CbGeAlD
Quetiapine—Hypersensitivity—Vinblastine—head and neck cancer	0.000672	0.00232	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000672	0.00232	CcSEcCtD
Quetiapine—Jaundice—Docetaxel—head and neck cancer	0.000661	0.00228	CcSEcCtD
Quetiapine—Stomatitis—Docetaxel—head and neck cancer	0.000661	0.00228	CcSEcCtD
Quetiapine—Conjunctivitis—Docetaxel—head and neck cancer	0.000659	0.00227	CcSEcCtD
Quetiapine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000658	0.00227	CcSEcCtD
Quetiapine—Leukopenia—Fluorouracil—head and neck cancer	0.000657	0.00226	CcSEcCtD
Quetiapine—Asthenia—Vinblastine—head and neck cancer	0.000655	0.00226	CcSEcCtD
Quetiapine—ADRA1A—head—head and neck cancer	0.000652	0.00363	CbGeAlD
Quetiapine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000641	0.00221	CcSEcCtD
Quetiapine—Epistaxis—Docetaxel—head and neck cancer	0.000639	0.0022	CcSEcCtD
Quetiapine—DRD2—head—head and neck cancer	0.000639	0.00356	CbGeAlD
Quetiapine—Convulsion—Fluorouracil—head and neck cancer	0.000636	0.00219	CcSEcCtD
Quetiapine—Agranulocytosis—Docetaxel—head and neck cancer	0.000632	0.00218	CcSEcCtD
Quetiapine—Myalgia—Fluorouracil—head and neck cancer	0.000625	0.00215	CcSEcCtD
Quetiapine—Chest pain—Fluorouracil—head and neck cancer	0.000625	0.00215	CcSEcCtD
Quetiapine—Diarrhoea—Vinblastine—head and neck cancer	0.000624	0.00215	CcSEcCtD
Quetiapine—ADRA2C—head—head and neck cancer	0.000621	0.00346	CbGeAlD
Quetiapine—Discomfort—Fluorouracil—head and neck cancer	0.000617	0.00213	CcSEcCtD
Quetiapine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000613	0.00211	CcSEcCtD
Quetiapine—Haemoglobin—Docetaxel—head and neck cancer	0.000611	0.00211	CcSEcCtD
Quetiapine—Rhinitis—Docetaxel—head and neck cancer	0.00061	0.0021	CcSEcCtD
Quetiapine—Hepatitis—Docetaxel—head and neck cancer	0.000608	0.0021	CcSEcCtD
Quetiapine—Haemorrhage—Docetaxel—head and neck cancer	0.000608	0.0021	CcSEcCtD
Quetiapine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000605	0.00209	CcSEcCtD
Quetiapine—Confusional state—Fluorouracil—head and neck cancer	0.000604	0.00208	CcSEcCtD
Quetiapine—Pharyngitis—Docetaxel—head and neck cancer	0.000604	0.00208	CcSEcCtD
Quetiapine—Dizziness—Vinblastine—head and neck cancer	0.000603	0.00208	CcSEcCtD
Quetiapine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000601	0.00207	CcSEcCtD
Quetiapine—HTR2A—trachea—head and neck cancer	0.000601	0.00335	CbGeAlD
Quetiapine—Oedema peripheral—Docetaxel—head and neck cancer	0.000599	0.00207	CcSEcCtD
Quetiapine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000599	0.00206	CcSEcCtD
Quetiapine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000598	0.00206	CcSEcCtD
Quetiapine—Asthenia—Hydroxyurea—head and neck cancer	0.000597	0.00206	CcSEcCtD
Quetiapine—Urethral disorder—Docetaxel—head and neck cancer	0.000596	0.00206	CcSEcCtD
Quetiapine—Infection—Fluorouracil—head and neck cancer	0.000595	0.00205	CcSEcCtD
Quetiapine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000587	0.00202	CcSEcCtD
Quetiapine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000586	0.00202	CcSEcCtD
Quetiapine—Visual impairment—Docetaxel—head and neck cancer	0.000586	0.00202	CcSEcCtD
Quetiapine—Tachycardia—Fluorouracil—head and neck cancer	0.000584	0.00201	CcSEcCtD
Quetiapine—Vomiting—Vinblastine—head and neck cancer	0.00058	0.002	CcSEcCtD
Quetiapine—Erythema multiforme—Docetaxel—head and neck cancer	0.000575	0.00198	CcSEcCtD
Quetiapine—Headache—Vinblastine—head and neck cancer	0.000572	0.00197	CcSEcCtD
Quetiapine—Anorexia—Fluorouracil—head and neck cancer	0.000571	0.00197	CcSEcCtD
Quetiapine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000569	0.00196	CcSEcCtD
Quetiapine—Eye disorder—Docetaxel—head and neck cancer	0.000569	0.00196	CcSEcCtD
Quetiapine—Cardiac disorder—Docetaxel—head and neck cancer	0.000565	0.00195	CcSEcCtD
Quetiapine—Hypotension—Fluorouracil—head and neck cancer	0.00056	0.00193	CcSEcCtD
Quetiapine—ADRA2A—thyroid gland—head and neck cancer	0.000559	0.00311	CbGeAlD
Quetiapine—Angiopathy—Docetaxel—head and neck cancer	0.000552	0.0019	CcSEcCtD
Quetiapine—Dizziness—Hydroxyurea—head and neck cancer	0.00055	0.0019	CcSEcCtD
Quetiapine—Immune system disorder—Docetaxel—head and neck cancer	0.00055	0.00189	CcSEcCtD
Quetiapine—Mediastinal disorder—Docetaxel—head and neck cancer	0.000548	0.00189	CcSEcCtD
Quetiapine—Chills—Docetaxel—head and neck cancer	0.000546	0.00188	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000546	0.00188	CcSEcCtD
Quetiapine—Nausea—Vinblastine—head and neck cancer	0.000542	0.00187	CcSEcCtD
Quetiapine—Insomnia—Fluorouracil—head and neck cancer	0.000542	0.00187	CcSEcCtD
Quetiapine—Paraesthesia—Fluorouracil—head and neck cancer	0.000538	0.00185	CcSEcCtD
Quetiapine—Dyspnoea—Fluorouracil—head and neck cancer	0.000534	0.00184	CcSEcCtD
Quetiapine—Mental disorder—Docetaxel—head and neck cancer	0.000533	0.00184	CcSEcCtD
Quetiapine—Somnolence—Fluorouracil—head and neck cancer	0.000532	0.00184	CcSEcCtD
Quetiapine—Malnutrition—Docetaxel—head and neck cancer	0.00053	0.00183	CcSEcCtD
Quetiapine—Vomiting—Hydroxyurea—head and neck cancer	0.000529	0.00182	CcSEcCtD
Quetiapine—Dyspepsia—Fluorouracil—head and neck cancer	0.000527	0.00182	CcSEcCtD
Quetiapine—Rash—Hydroxyurea—head and neck cancer	0.000525	0.00181	CcSEcCtD
Quetiapine—Dermatitis—Hydroxyurea—head and neck cancer	0.000524	0.00181	CcSEcCtD
Quetiapine—Headache—Hydroxyurea—head and neck cancer	0.000521	0.0018	CcSEcCtD
Quetiapine—Decreased appetite—Fluorouracil—head and neck cancer	0.000521	0.00179	CcSEcCtD
Quetiapine—Dysgeusia—Docetaxel—head and neck cancer	0.000519	0.00179	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000517	0.00178	CcSEcCtD
Quetiapine—Back pain—Docetaxel—head and neck cancer	0.000512	0.00177	CcSEcCtD
Quetiapine—Pain—Fluorouracil—head and neck cancer	0.000512	0.00177	CcSEcCtD
Quetiapine—Muscle spasms—Docetaxel—head and neck cancer	0.000509	0.00176	CcSEcCtD
Quetiapine—HRH1—head—head and neck cancer	0.000505	0.00281	CbGeAlD
Quetiapine—ADRA2A—head—head and neck cancer	0.000496	0.00276	CbGeAlD
Quetiapine—Nausea—Hydroxyurea—head and neck cancer	0.000494	0.0017	CcSEcCtD
Quetiapine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000493	0.0017	CcSEcCtD
Quetiapine—Anaemia—Docetaxel—head and neck cancer	0.00049	0.00169	CcSEcCtD
Quetiapine—Syncope—Docetaxel—head and neck cancer	0.000475	0.00164	CcSEcCtD
Quetiapine—Leukopenia—Docetaxel—head and neck cancer	0.000474	0.00163	CcSEcCtD
Quetiapine—Body temperature increased—Fluorouracil—head and neck cancer	0.000473	0.00163	CcSEcCtD
Quetiapine—Palpitations—Docetaxel—head and neck cancer	0.000468	0.00161	CcSEcCtD
Quetiapine—Loss of consciousness—Docetaxel—head and neck cancer	0.000465	0.0016	CcSEcCtD
Quetiapine—Cough—Docetaxel—head and neck cancer	0.000462	0.00159	CcSEcCtD
Quetiapine—Convulsion—Docetaxel—head and neck cancer	0.000459	0.00158	CcSEcCtD
Quetiapine—Hypertension—Docetaxel—head and neck cancer	0.000457	0.00158	CcSEcCtD
Quetiapine—Chest pain—Docetaxel—head and neck cancer	0.000451	0.00155	CcSEcCtD
Quetiapine—Myalgia—Docetaxel—head and neck cancer	0.000451	0.00155	CcSEcCtD
Quetiapine—Arthralgia—Docetaxel—head and neck cancer	0.000451	0.00155	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000448	0.00154	CcSEcCtD
Quetiapine—ABCB1—epithelium—head and neck cancer	0.000445	0.00248	CbGeAlD
Quetiapine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000441	0.00152	CcSEcCtD
Quetiapine—Dry mouth—Docetaxel—head and neck cancer	0.000441	0.00152	CcSEcCtD
Quetiapine—Confusional state—Docetaxel—head and neck cancer	0.000436	0.0015	CcSEcCtD
Quetiapine—ADRA2C—lymph node—head and neck cancer	0.000435	0.00242	CbGeAlD
Quetiapine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000432	0.00149	CcSEcCtD
Quetiapine—Infection—Docetaxel—head and neck cancer	0.000429	0.00148	CcSEcCtD
Quetiapine—Shock—Docetaxel—head and neck cancer	0.000425	0.00147	CcSEcCtD
Quetiapine—Nervous system disorder—Docetaxel—head and neck cancer	0.000424	0.00146	CcSEcCtD
Quetiapine—Pruritus—Fluorouracil—head and neck cancer	0.000424	0.00146	CcSEcCtD
Quetiapine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000423	0.00146	CcSEcCtD
Quetiapine—Tachycardia—Docetaxel—head and neck cancer	0.000422	0.00145	CcSEcCtD
Quetiapine—HTR2A—head—head and neck cancer	0.000422	0.00235	CbGeAlD
Quetiapine—Skin disorder—Docetaxel—head and neck cancer	0.00042	0.00145	CcSEcCtD
Quetiapine—Anorexia—Docetaxel—head and neck cancer	0.000412	0.00142	CcSEcCtD
Quetiapine—Diarrhoea—Fluorouracil—head and neck cancer	0.00041	0.00141	CcSEcCtD
Quetiapine—Hypotension—Docetaxel—head and neck cancer	0.000404	0.00139	CcSEcCtD
Quetiapine—Dizziness—Fluorouracil—head and neck cancer	0.000396	0.00137	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000394	0.00136	CcSEcCtD
Quetiapine—ABCB1—trachea—head and neck cancer	0.000394	0.00219	CbGeAlD
Quetiapine—Insomnia—Docetaxel—head and neck cancer	0.000391	0.00135	CcSEcCtD
Quetiapine—Paraesthesia—Docetaxel—head and neck cancer	0.000388	0.00134	CcSEcCtD
Quetiapine—Dyspnoea—Docetaxel—head and neck cancer	0.000385	0.00133	CcSEcCtD
Quetiapine—Somnolence—Docetaxel—head and neck cancer	0.000384	0.00132	CcSEcCtD
Quetiapine—CYP2D6—head—head and neck cancer	0.000384	0.00214	CbGeAlD
Quetiapine—Vomiting—Fluorouracil—head and neck cancer	0.000381	0.00131	CcSEcCtD
Quetiapine—Dyspepsia—Docetaxel—head and neck cancer	0.00038	0.00131	CcSEcCtD
Quetiapine—Rash—Fluorouracil—head and neck cancer	0.000378	0.0013	CcSEcCtD
Quetiapine—Dermatitis—Fluorouracil—head and neck cancer	0.000377	0.0013	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—head and neck cancer	0.000376	0.0013	CcSEcCtD
Quetiapine—Headache—Fluorouracil—head and neck cancer	0.000375	0.00129	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000373	0.00129	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—head and neck cancer	0.000373	0.00128	CcSEcCtD
Quetiapine—Pain—Docetaxel—head and neck cancer	0.00037	0.00127	CcSEcCtD
Quetiapine—Constipation—Docetaxel—head and neck cancer	0.00037	0.00127	CcSEcCtD
Quetiapine—Feeling abnormal—Docetaxel—head and neck cancer	0.000356	0.00123	CcSEcCtD
Quetiapine—Nausea—Fluorouracil—head and neck cancer	0.000356	0.00123	CcSEcCtD
Quetiapine—HRH1—lymph node—head and neck cancer	0.000353	0.00197	CbGeAlD
Quetiapine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000353	0.00122	CcSEcCtD
Quetiapine—ADRA2A—lymph node—head and neck cancer	0.000347	0.00193	CbGeAlD
Quetiapine—ABCB1—lymphoid tissue—head and neck cancer	0.000343	0.00191	CbGeAlD
Quetiapine—Body temperature increased—Docetaxel—head and neck cancer	0.000342	0.00118	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—head and neck cancer	0.000342	0.00118	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—head and neck cancer	0.000318	0.0011	CcSEcCtD
Quetiapine—ABCB1—thyroid gland—head and neck cancer	0.000311	0.00174	CbGeAlD
Quetiapine—Asthenia—Docetaxel—head and neck cancer	0.00031	0.00107	CcSEcCtD
Quetiapine—Pruritus—Docetaxel—head and neck cancer	0.000306	0.00105	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—head and neck cancer	0.000296	0.00102	CcSEcCtD
Quetiapine—Dizziness—Docetaxel—head and neck cancer	0.000286	0.000985	CcSEcCtD
Quetiapine—ABCB1—head—head and neck cancer	0.000276	0.00154	CbGeAlD
Quetiapine—Vomiting—Docetaxel—head and neck cancer	0.000275	0.000947	CcSEcCtD
Quetiapine—Rash—Docetaxel—head and neck cancer	0.000273	0.000939	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—head and neck cancer	0.000272	0.000939	CcSEcCtD
Quetiapine—Headache—Docetaxel—head and neck cancer	0.000271	0.000933	CcSEcCtD
Quetiapine—Nausea—Docetaxel—head and neck cancer	0.000257	0.000885	CcSEcCtD
Quetiapine—ABCB1—lymph node—head and neck cancer	0.000193	0.00108	CbGeAlD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	1.37e-05	9.96e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.36e-05	9.91e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.36e-05	9.91e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	1.36e-05	9.88e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.34e-05	9.75e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	1.34e-05	9.73e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.34e-05	9.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	1.34e-05	9.72e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	1.34e-05	9.72e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	1.33e-05	9.69e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	1.33e-05	9.66e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	1.33e-05	9.66e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MAPK1—head and neck cancer	1.33e-05	9.65e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—head and neck cancer	1.33e-05	9.65e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	1.32e-05	9.64e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.32e-05	9.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTEN—head and neck cancer	1.32e-05	9.6e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.32e-05	9.58e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	1.31e-05	9.57e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	1.31e-05	9.55e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	1.31e-05	9.54e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—head and neck cancer	1.31e-05	9.53e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	1.31e-05	9.53e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MAPK1—head and neck cancer	1.31e-05	9.53e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—head and neck cancer	1.31e-05	9.52e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	1.31e-05	9.52e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	1.3e-05	9.49e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	1.3e-05	9.46e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.3e-05	9.46e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	1.3e-05	9.46e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	1.29e-05	9.43e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—head and neck cancer	1.29e-05	9.41e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—head and neck cancer	1.29e-05	9.4e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	1.29e-05	9.4e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.29e-05	9.38e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—head and neck cancer	1.29e-05	9.36e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—head and neck cancer	1.28e-05	9.34e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—head and neck cancer	1.28e-05	9.33e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	1.28e-05	9.31e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	1.28e-05	9.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—head and neck cancer	1.28e-05	9.3e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.28e-05	9.29e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	1.27e-05	9.28e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.27e-05	9.22e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—head and neck cancer	1.26e-05	9.21e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—PIK3CA—head and neck cancer	1.26e-05	9.18e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	1.26e-05	9.18e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.26e-05	9.18e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—head and neck cancer	1.26e-05	9.15e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.26e-05	9.14e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.25e-05	9.12e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCND1—head and neck cancer	1.25e-05	9.09e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.25e-05	9.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCND1—head and neck cancer	1.24e-05	9.06e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	1.24e-05	9.04e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HRAS—head and neck cancer	1.24e-05	9e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—head and neck cancer	1.24e-05	9e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HRAS—head and neck cancer	1.24e-05	8.99e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	1.23e-05	8.97e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.23e-05	8.97e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	1.23e-05	8.95e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HRAS—head and neck cancer	1.23e-05	8.94e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	1.23e-05	8.92e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—head and neck cancer	1.22e-05	8.88e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.22e-05	8.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	1.21e-05	8.84e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	8.82e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	8.8e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—head and neck cancer	1.21e-05	8.8e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—head and neck cancer	1.21e-05	8.79e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	1.21e-05	8.78e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	1.21e-05	8.77e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HRAS—head and neck cancer	1.2e-05	8.75e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.2e-05	8.75e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—head and neck cancer	1.2e-05	8.75e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.2e-05	8.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	1.19e-05	8.7e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.19e-05	8.68e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	1.19e-05	8.66e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.19e-05	8.64e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.18e-05	8.62e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—head and neck cancer	1.18e-05	8.61e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	8.61e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	1.18e-05	8.6e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	1.18e-05	8.6e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	8.59e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.18e-05	8.58e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	1.18e-05	8.56e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	8.53e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.17e-05	8.53e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—head and neck cancer	1.17e-05	8.51e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—head and neck cancer	1.17e-05	8.49e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	1.16e-05	8.45e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	1.16e-05	8.44e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.16e-05	8.43e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.16e-05	8.41e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	1.15e-05	8.38e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—head and neck cancer	1.15e-05	8.34e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.14e-05	8.32e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.14e-05	8.32e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.14e-05	8.31e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.14e-05	8.3e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.14e-05	8.3e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	1.14e-05	8.27e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	1.14e-05	8.27e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.13e-05	8.26e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.13e-05	8.26e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—head and neck cancer	1.12e-05	8.13e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—head and neck cancer	1.11e-05	8.1e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.11e-05	8.1e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	1.1e-05	8.03e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	1.1e-05	8.03e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.1e-05	8.03e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.1e-05	8.02e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—head and neck cancer	1.1e-05	8e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—head and neck cancer	1.1e-05	8e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	7.97e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.09e-05	7.97e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	7.95e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—head and neck cancer	1.09e-05	7.95e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—head and neck cancer	1.09e-05	7.94e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	7.93e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.09e-05	7.91e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.09e-05	7.9e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	7.9e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	7.89e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	7.89e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.08e-05	7.88e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	7.87e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	7.85e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.08e-05	7.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	1.07e-05	7.82e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—head and neck cancer	1.07e-05	7.82e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.07e-05	7.8e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.07e-05	7.8e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—head and neck cancer	1.06e-05	7.75e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	1.06e-05	7.75e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—head and neck cancer	1.06e-05	7.73e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	1.06e-05	7.73e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.05e-05	7.66e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—head and neck cancer	1.05e-05	7.65e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	1.05e-05	7.65e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.05e-05	7.61e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—head and neck cancer	1.04e-05	7.6e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.04e-05	7.54e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	7.52e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—head and neck cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	7.47e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	1.03e-05	7.46e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	1.02e-05	7.4e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—head and neck cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1e-05	7.29e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—head and neck cancer	1e-05	7.29e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	9.96e-06	7.25e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—head and neck cancer	9.92e-06	7.22e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	9.9e-06	7.2e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—head and neck cancer	9.87e-06	7.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	9.86e-06	7.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	9.85e-06	7.17e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—head and neck cancer	9.85e-06	7.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	9.85e-06	7.17e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	9.84e-06	7.17e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	9.83e-06	7.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—head and neck cancer	9.83e-06	7.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	9.8e-06	7.13e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	9.8e-06	7.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	9.77e-06	7.11e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—head and neck cancer	9.77e-06	7.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	9.67e-06	7.04e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	9.67e-06	7.04e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	9.65e-06	7.02e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	9.64e-06	7.02e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—head and neck cancer	9.63e-06	7.01e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	9.58e-06	6.97e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—head and neck cancer	9.57e-06	6.97e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—head and neck cancer	9.52e-06	6.93e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	9.48e-06	6.9e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	9.42e-06	6.86e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	9.42e-06	6.86e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—head and neck cancer	9.4e-06	6.84e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—head and neck cancer	9.35e-06	6.81e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—head and neck cancer	9.34e-06	6.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	9.3e-06	6.77e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—head and neck cancer	9.28e-06	6.75e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	9.28e-06	6.75e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—head and neck cancer	9.26e-06	6.74e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	9.16e-06	6.67e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—head and neck cancer	9.12e-06	6.64e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	9.12e-06	6.64e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	9.11e-06	6.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	8.96e-06	6.53e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	8.96e-06	6.52e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	8.86e-06	6.45e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	8.72e-06	6.35e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	8.69e-06	6.33e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—head and neck cancer	8.59e-06	6.25e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	8.55e-06	6.22e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	8.53e-06	6.21e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	8.52e-06	6.21e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	8.5e-06	6.19e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	8.48e-06	6.17e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—head and neck cancer	8.4e-06	6.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	8.39e-06	6.11e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	8.37e-06	6.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	8.37e-06	6.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—head and neck cancer	8.28e-06	6.03e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—head and neck cancer	8.27e-06	6.02e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—head and neck cancer	8.25e-06	6.01e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—head and neck cancer	8.23e-06	5.99e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—head and neck cancer	8.2e-06	5.97e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—head and neck cancer	8.12e-06	5.91e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	8.1e-06	5.9e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	8.08e-06	5.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	8.04e-06	5.85e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—head and neck cancer	8.04e-06	5.85e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	7.91e-06	5.76e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—head and neck cancer	7.89e-06	5.75e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	7.87e-06	5.73e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—head and neck cancer	7.84e-06	5.71e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	7.82e-06	5.69e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	7.78e-06	5.66e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	7.77e-06	5.65e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	7.74e-06	5.64e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	7.7e-06	5.6e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—head and neck cancer	7.6e-06	5.53e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	7.52e-06	5.48e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	7.2e-06	5.24e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—head and neck cancer	7.1e-06	5.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	6.98e-06	5.08e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—head and neck cancer	6.97e-06	5.07e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—head and neck cancer	6.96e-06	5.07e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	6.95e-06	5.06e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—head and neck cancer	6.92e-06	5.04e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	6.86e-06	4.99e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	6.84e-06	4.98e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	6.59e-06	4.8e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.44e-06	4.69e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.43e-06	4.68e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	6.35e-06	4.63e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.06e-06	4.41e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—head and neck cancer	5.62e-06	4.09e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—head and neck cancer	5.38e-06	3.92e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—head and neck cancer	5.25e-06	3.83e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—head and neck cancer	4.95e-06	3.6e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.96e-06	2.88e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.24e-06	2.36e-05	CbGpPWpGaD
